under

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

6 months ago

Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation

WALTHAM, Mass., Oct. 15, 2025 /PRNewswire/ -- We are proud to announce that Advanced Instruments and Nova Biomedical are now…

6 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

October 10, 2025 17:16 ET  | Source: Bluejay Diagnostics, Inc. ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…

6 months ago

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2025 16:41 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

6 months ago

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2025 16:05 ET  | Source: Vera Therapeutics BRISBANE, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc.…

6 months ago

Voho Announces CEO Asfandyar Malik Named to Forbes 30 Under 30 for Innovation in AI and Crypto

October 10, 2025 10:00 ET  | Source: Voho London, UK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Voho, a leading provider…

6 months ago

ZTE hosts Global Summit & User Congress 2025 in Milan under the theme “Expanding Intelligence, Creating Possibilities”

MILAN, Oct. 9, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication…

6 months ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

ROCKAWAY, N.J., Oct. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness…

7 months ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:01 ET  | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics,…

7 months ago

Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:15 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.…

7 months ago